Recent News

• 04.08.2025 - KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan
• 04.08.2025 - KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan
• 04.07.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.02.2025 - KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 04.02.2025 - KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.31.2025 - KalVista Pharmaceuticals to Present at 24th Annual Needham Virtual Healthcare Conference
• 03.31.2025 - KalVista Pharmaceuticals to Present at 24th Annual Needham Virtual Healthcare Conference
• 03.25.2025 - Investor Webcast
• 03.25.2025 - KalVista Pharmaceuticals Announces Early Completion of Enrollment in KONFIDENT-KID Pediatric HAE Trial
• 03.25.2025 - KalVista Pharmaceuticals Announces Early Completion of Enrollment in KONFIDENT-KID Pediatric HAE Trial

Recent Filings

• 04.08.2025 - 8-K Current report
• 04.08.2025 - EX-99.1 EX-99.1
• 03.17.2025 - 8-K Current report
• 03.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 03.12.2025 - EX-99.1 EX-99.1
• 03.12.2025 - 8-K Current report